BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29790787)

  • 61. Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False.
    Desjardin M; Bonhomme B; Le Bail B; Evrard S; Brouste V; Desolneux G; Fonck M; Bécouarn Y; Béchade D
    Clin Med Insights Oncol; 2019; 13():1179554918825450. PubMed ID: 30718969
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Necessity of clinical information in surgical pathology.
    Nakhleh RE; Gephardt G; Zarbo RJ
    Arch Pathol Lab Med; 1999 Jul; 123(7):615-9. PubMed ID: 10388918
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Grossing and reporting of colorectal cancer resection specimens: An evidence-based approach.
    Katti SV; Paulose RR; Malipatil B; Verma NS
    Indian J Cancer; 2020; 57(3):239-252. PubMed ID: 32788434
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma.
    Kendall T; Overi D; Guido M; Braconi C; Banales J; Cardinale V; Gaudio E; Groot Koerkamp B; Carpino G
    JHEP Rep; 2024 Jun; 6(6):101067. PubMed ID: 38699072
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Formatting pathology reports: applying four design principles to improve communication and patient safety.
    Valenstein PN
    Arch Pathol Lab Med; 2008 Jan; 132(1):84-94. PubMed ID: 18181680
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The evolving landscape of anatomic pathology.
    Pisapia P; L'Imperio V; Galuppini F; Sajjadi E; Russo A; Cerbelli B; Fraggetta F; d'Amati G; Troncone G; Fassan M; Fusco N; Pagni F; Malapelle U
    Crit Rev Oncol Hematol; 2022 Oct; 178():103776. PubMed ID: 35934262
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cancer: A pathologist's journey from morphology to molecular.
    Sahai K; Ahuja A
    Med J Armed Forces India; 2022 Jul; 78(3):255-263. PubMed ID: 35855703
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Real-time fluorescence imaging for cancer surgery: a pathologist's perspective.
    Sarode SC; Sarode GS
    Lancet Oncol; 2021 Jul; 22(7):e282. PubMed ID: 34197745
    [No Abstract]   [Full Text] [Related]  

  • 69. Real-time fluorescence imaging for cancer surgery: a pathologist's perspective - Authors' reply.
    Lauwerends LJ; van Driel PBAA; Koljenović S; Vahrmeijer AL; Keereweer S
    Lancet Oncol; 2021 Jul; 22(7):e283. PubMed ID: 34197746
    [No Abstract]   [Full Text] [Related]  

  • 70. KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation.
    Kato K; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Uemura M; Asaoka T; Shimizu J; Doki Y; Eguchi H
    Cancer Sci; 2024 May; 115(5):1520-1535. PubMed ID: 38475666
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Colorectal liver metastases: Current management and future perspectives.
    Martin J; Petrillo A; Smyth EC; Shaida N; Khwaja S; Cheow HK; Duckworth A; Heister P; Praseedom R; Jah A; Balakrishnan A; Harper S; Liau S; Kosmoliaptsis V; Huguet E
    World J Clin Oncol; 2020 Oct; 11(10):761-808. PubMed ID: 33200074
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of postoperative oxaliplatin- or irinotecan-based chemotherapy after curative resection of synchronous liver metastases from colorectal cancer.
    Hsu HC; Chou WC; Shen WC; Wu CE; Chen JS; Liau CT; Lin YC; Yang TS
    Anticancer Res; 2013 Aug; 33(8):3317-25. PubMed ID: 23898098
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Colorectal Liver Metastases: A Pathologist's Guide to Creating an Informative Report and Improving Patient Care.
    Moreno Prats M; Sasatomi E; Stevenson HL
    Arch Pathol Lab Med; 2019 Feb; 143(2):251-257. PubMed ID: 29790787
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
    Stevenson HL; Prats MM; Sasatomi E
    BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol.
    Fonseca GM; Herman P; Faraj SF; Kruger JAP; Coelho FF; Jeismann VB; Cecconello I; Alves VAF; Pawlik TM; de Mello ES
    Histopathology; 2018 Feb; 72(3):377-390. PubMed ID: 28858385
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.